Transgene Biotek Limited

Share · INE773D01018 (XBOM)

Overview

No Price

Closing Price XBOM 04.02.2026: 1,97 INR

04.02.2026 09:58

Current Prices from Transgene Biotek Limited

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
MSE	TRABI.BO	INR	04.02.2026 09:58	1,97 INR	-0,11 INR -5,29 %

Share Float & Liquidity

Free Float 68,48 %

Shares Float 51,89 M

Shares Outstanding 75,77 M

Company Profile for Transgene Biotek Limited Share

Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. It involves in the production and oral formulation of different proteins using TrabiORAL technology. The firm's products portfolio includes TrabiDHA, Tacrolimus, and Orlistat. The company was founded by K. Koteswara Rao in 1991 and is headquartered in Hyderabad, India.

AI Analysis of Transgene Biotek Limited

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Transgene Biotek Limited

No AI threads available for this company yet.

Company Data

Name Transgene Biotek Limited

Company Transgene Biotek Limited

Website http://www.transgenebiotek.com

Primary Exchange

MSE

ISIN INE773D01018

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Koteswara Rao Kanuru

Market Capitalization 158 Mio

Country India

Currency INR

Employees -

Address Plot No. 69 & 70, Hyderabad

IPO Date 2001-12-31

Ticker Symbols

Name	Symbol
MSE	TRABI.BO

More Shares

Investors who hold Transgene Biotek Limited also have the following shares in their portfolio:

ISHS WATER DLA ETF

OESTERREICHISCHE KONTROLLBANK AG 0.750% GTD NTS 07/03/22 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog